查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595253

儿科疫苗市场：按技术、疫苗、适应症和最终用户划分 - 全球预测 2025-2030

Pediatric Vaccines Market by Technology (Attenuated Live Viruses, Conjugates, Inactivated Viruses), Vaccine (Monovalent, Multivalent), Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年儿科疫苗市场规模为190.7亿美元，预计2024年将达212.6亿美元，复合年增长率为11.57%，2030年将达410.6亿美元。

儿科疫苗市场是一个广泛的市场，涵盖了从婴幼儿到青春期儿童的免疫需求。现代儿科疫苗旨在预防多种感染疾病，包括麻疹、德国麻疹、脊髓灰质炎、小儿麻痹、流感和水痘。实现群体免疫和预防疫情的目标强调了对这些疫苗的需求。这些疫苗用于公共和私人医疗机构，包括诊所、医院和药房疫苗接种中心，用于常规免疫计划和特殊免疫宣传活动。

主要市场统计
基准年[2023] 190.7亿美元
预测年份 [2024] 212.6亿美元
预测年份 [2030] 410.6亿美元
复合年增长率（%） 11.57%

该市场的主要推动力是人们对疫苗接种益处的认识不断提高、政府的强制要求以及世界卫生组织和联合国儿童基金会等组织的全球卫生倡议。疫苗技术的进步、官民合作关係以及儿童传染病发病率的上升也起到了帮助作用。此外，用于开发新型疫苗的研发投资正在增加，尤其是 mRNA 技术的出现提供了利润丰厚的机会。然而，市场成长受到疫苗犹豫、供应链中断、市场开拓高成本以及阻碍新疫苗推出的严格监管要求的阻碍。

为了抓住潜在的机会，企业应专注于给药方法的创新，例如无针技术，并寻求扩大疫苗保护范围。专注于数位健康整合将有助于提高疫苗追踪和疫苗接种效率。可以透过制定有效的传播策略来应对挑战和反制错误讯息，并建立伙伴关係以扩大新兴市场的准入，从而促进市场扩张。继续研究联合疫苗和改善低温运输物流是业务成长的关键领域。市场动态是动态的，其特点是技术快速发展、监管监督和业务复杂性，但为成功应对这些挑战的公司提供了巨大的创新和扩张潜力。

市场动态：揭示快速发展的儿科疫苗市场的关键市场洞察

供需的动态交互作用正在改变儿科疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 儿科族群感染疾病率不断上升
    • 疫苗接种的好处，例如预防严重和防止感染他人
    • 政府介入儿童疫苗的使用
  • 市场限制因素
    • 缺乏强制疫苗接种
    • 与儿童疫苗相关的轻微副作用
  • 市场机会
    • 强大的后期研发管线和新药认证
    • 婴幼儿定期接种疫苗
  • 市场挑战
    • 没有统一的召回或提醒系统，缺乏人员

波特五力：驾驭儿科疫苗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解儿科疫苗市场的外部影响

外部宏观环境因素在塑造儿科疫苗市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解儿科疫苗市场的竞争格局

对儿科疫苗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵儿科疫苗市场供应商的绩效评估

FPNV定位矩阵是评估儿科疫苗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製儿科疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对儿科疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 儿科人群感染疾病率增加
      • 疫苗接种的好处包括预防严重疾病和预防疾病传播给他人。
      • 政府介入儿童疫苗的使用
    • 抑制因素
      • 强制疫苗接种落实不到位
      • 与儿童疫苗相关的轻微副作用
    • 机会
      • 强大的后期研发管线和新药认证
      • 用于婴幼儿免疫接种的常规疫苗
    • 任务
      • 没有统一的召回或提醒系统，人员配备不足
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章儿科疫苗市场：依技术分类

  • 减毒活病毒
  • 共轭形式
  • 灭活病毒
  • 多醣
  • 重组
  • 次单元
  • 类毒素

第七章 儿科疫苗市场疫苗

  • 单价
  • 多效价的

第八章以适应症分類的儿科疫苗市场

  • B型流感嗜血桿菌
  • 肝炎
  • 人类乳突病毒
  • 麻疹
  • 甲型脑膜炎
  • 腮腺炎
  • 肺炎链球菌感染
  • 脊髓灰质炎
  • 轮状病毒
  • 德国麻疹
  • 破伤风
  • 黄热病

第九章儿科疫苗市场：依最终用户分类

  • 医院
  • 小儿科诊所
  • 研究机构

第十章美洲儿科疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区儿科疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲儿科疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Indian Immunologicals Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mitsubishi Chemical Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • SINOVAC Biotech Ltd.
  • Zoetis Inc.
Product Code: MRR-030EE4851566

The Pediatric Vaccines Market was valued at USD 19.07 billion in 2023, expected to reach USD 21.26 billion in 2024, and is projected to grow at a CAGR of 11.57%, to USD 41.06 billion by 2030.

The pediatric vaccines market encompasses a broad scope, targeting the immunization needs of children from infancy through adolescence. Modern pediatric vaccines are designed to protect against a variety of infectious diseases, including measles, mumps, rubella, polio, influenza, and chickenpox, among others. The necessity of these vaccines is underscored by the objective of achieving herd immunity and preventing outbreaks, which is critical for public health. They find applications in public and private healthcare settings, including clinics, hospitals, and pharmacy-based immunization centers, catering to both routine immunization schedules and special vaccination campaigns.

KEY MARKET STATISTICS
Base Year [2023] USD 19.07 billion
Estimated Year [2024] USD 21.26 billion
Forecast Year [2030] USD 41.06 billion
CAGR (%) 11.57%

The market is primarily driven by increased awareness of the benefits of immunization, government mandates, and global health initiatives from organizations such as WHO and UNICEF. Boosting factors include advancements in vaccine technology, public-private partnerships, and rising incidence of contagious diseases in children. Additionally, growing investments in R&D efforts for novel vaccine development provide lucrative opportunities, especially with the emergence of mRNA technologies. However, market growth is challenged by vaccine hesitancy, supply chain disruptions, high costs of development, and stringent regulatory requirements, which can impede the introduction of new vaccines.

To seize potential opportunities, companies should focus on innovations in delivery methods, such as needle-free technologies, and explore the extension of vaccine protection durations. Emphasizing digital health integration can help enhance vaccine tracking and coverage efficiency. Addressing challenges, fostering effective communication strategies to combat misinformation, and fostering collaborations for expanding access in emerging markets can facilitate market expansion. Continued research into combination vaccines and better cold chain logistics are pivotal areas for business growth. The pediatric vaccines market is dynamic, characterized by rapid technological evolution, regulatory scrutiny, and operational complexities, yet it offers vast potential for innovation and expansion for firms that navigate these challenges adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Vaccines Market

The Pediatric Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases in the pediatric population
    • Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
    • Government intervention for the use of pediatric vaccines
  • Market Restraints
    • Lack of implementation of mandatory vaccination
    • Slight-side effects associated with pediatric vaccines
  • Market Opportunities
    • Strong late-stage pipeline and new drug approvals
    • Routinized vaccines used in immunization of infants and children
  • Market Challenges
    • No uniform recall or reminder system and staff shortages

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Vaccines Market

A detailed market share analysis in the Pediatric Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Vaccines Market

A strategic analysis of the Pediatric Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Vaccines Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., SINOVAC Biotech Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
  • Based on Vaccine, market is studied across Monovalent and Multivalent.
  • Based on Indication, market is studied across Haemophilus Influenzae Type B, Hepatitis, Human Papillomavirus , Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
  • Based on End User, market is studied across Hospital, Pediatric Clinic, and Research Organization.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
      • 5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
      • 5.1.1.3. Government intervention for the use of pediatric vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of implementation of mandatory vaccination
      • 5.1.2.2. Slight-side effects associated with pediatric vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Strong late-stage pipeline and new drug approvals
      • 5.1.3.2. Routinized vaccines used in immunization of infants and children
    • 5.1.4. Challenges
      • 5.1.4.1. No uniform recall or reminder system and staff shortages
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Vaccines Market, by Technology

  • 6.1. Introduction
  • 6.2. Attenuated Live Viruses
  • 6.3. Conjugates
  • 6.4. Inactivated Viruses
  • 6.5. Polysaccharides
  • 6.6. Recombinant
  • 6.7. Subunits
  • 6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine

  • 7.1. Introduction
  • 7.2. Monovalent
  • 7.3. Multivalent

8. Pediatric Vaccines Market, by Indication

  • 8.1. Introduction
  • 8.2. Haemophilus Influenzae Type B
  • 8.3. Hepatitis
  • 8.4. Human Papillomavirus
  • 8.5. Measles
  • 8.6. Meningitis A
  • 8.7. Mumps
  • 8.8. Pneumococcal Diseases
  • 8.9. Polio
  • 8.10. Rotaviruses
  • 8.11. Rubella
  • 8.12. Tetanus
  • 8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Pediatric Clinic
  • 9.4. Research Organization

10. Americas Pediatric Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pediatric Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pediatric Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Bavarian Nordic A/S
  • 3. CSL Limited
  • 4. Eli Lilly and Company
  • 5. GlaxoSmithKline PLC
  • 6. Indian Immunologicals Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Merck & Co., Inc.
  • 9. Mitsubishi Chemical Corporation
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Sanofi S.A.
  • 13. Serum Institute of India Pvt. Ltd.
  • 14. SINOVAC Biotech Ltd.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 204. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023